Roy Dennis Bloom

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
One Founders Pavilion
3400 Spruce Street
Philadelphia, Pa 19104-6144
Office: (215) 662-4643
Fax: (215) 615-0349
Education:
BSc (Physiology and Biochemistry)
University of Witwatersrand, 1980.
M.B.B.Ch.
University of Witwatersrand, 1983.
Permanent link
 

Description of Research Expertise

Kidney transplant outcomes, Post-transplant diabetes mellitus, hepatitis C in kidney transplantation

Description of Itmat Expertise

Dr. Bloom engages in clinical outcomes research, particularly pertaining to hepatitis C, transplant associated hyperglycemia and combined liver-kidney transplantation. He also has an active interest in immunosuppressive drug trials, both investigator-initiated and biopharmaceutical-initiated multicenter studies.

Selected Publications

Sawinski D, Kaur N, Ajeti A, Trofe-Clark J, Lim M, Bleicher M, Goral S, Forde KA and Bloom RD. : Successful treatment of Hepatitis C in renal transplant recipients with direct-acting antiviral agents. American Journal of Transplantation (in press) 2016.

Cohen JB, Bloom RD, Reese PP, Porrett PM, Forde KM, Sawinski DL.: National Outcomes of Kidney Transplantation from Deceased Diabetic Donors. Kidney International (in press) 2016.

Choudhury RA, Reese PP, Goldberg DS, Bloom RD, Sawinski DL, Abt PL: A Paired Kidney Analysis of Multiorgan Transplantation: Implications for Allograft Survival. Transplantation (in press) 2016.

Lim MA, Kohli J, Bloom RD: Immunosuppression for Kidney Transplantation: Where are we now and where are we going? Transplantation Reviews (in press), 2016.

Sawinski D, Bloom RD: Novel Hepatitis C Treatment and the Impact on Kidney Transplantation. Transplantation 99(12): 2458-66, December 2015.

Reese PR, Shults J, Bloom RD, Mussell A, Harhay MN, Abt P, Levine M, Johansen KL, Karlawish JT, Feldman HI: Functional status, time to transplant, and survival benefit of kidney transplantation among wait-listed candidates. American Journal of Kidney Diseases 66(5): 837-45, November 2015.

Sawinski D, Forde KA, Eddinger K, Troxel AB, Blumberg E, Tebas P, Abt PL, Bloom RD: Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients. Kidney International 88(2): 341-9, August 2015.

Richterman A, Sawinski D, Reese PP, Lee DH, Clauss H, Hasz RD, Thomasson A, Goldberg D, Abt PL, Forde KA, Bloom RD, Doll S, Brady KA, Blumberg E: An Assessment of HIV-Infected Patients Dying in Care for Deceased Organ Donation in a United States Urban Center American Journal of Transplantation 15(8): 2105-16, August 2015.

Sawinski D, Goldberg DS, Blumberg E, Abt PL, Bloom RD, Forde KA. : Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States Clinical Infectious Diseases (in press), June 2015.

Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Monet, OrlowskiJP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, and Kumar D: Solid Organ Transplantation from Hepatitis B Virus Positive Donors: Consensus Guidelines for Recipient Management. American Journal of Transplantation 15(5): 1162-72, May 2015.

back to top
Last updated: 03/20/2016
The Trustees of the University of Pennsylvania